(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 37.36%18.81M | -17.46%5.62M | -6.46%13.69M | 4.13%6.81M | 104.18%14.64M | 161.00%6.54M | -63.97%7.17M | -81.62%2.51M | 4.54%19.9M | 53.23%13.63M |
Operating income | 37.36%18.81M | -17.46%5.62M | -6.46%13.69M | 4.13%6.81M | 104.18%14.64M | 161.00%6.54M | -63.97%7.17M | -81.62%2.51M | 4.54%19.9M | 53.23%13.63M |
Cost of sales | -35.80%-15.76M | 7.20%-5.39M | 0.05%-11.6M | -10.04%-5.81M | -61.18%-11.61M | -81.28%-5.28M | 67.76%-7.2M | 76.19%-2.91M | -72.82%-22.34M | -121.62%-12.23M |
Operating expenses | -35.80%-15.76M | 7.20%-5.39M | 0.05%-11.6M | -10.04%-5.81M | -61.18%-11.61M | -81.28%-5.28M | 67.76%-7.2M | 76.19%-2.91M | -72.82%-22.34M | -121.62%-12.23M |
Gross profit | 46.05%3.05M | -77.02%230K | -31.01%2.09M | -20.62%1M | 9,005.88%3.03M | 410.59%1.26M | 98.61%-34K | -129.00%-406K | -139.94%-2.44M | -58.53%1.4M |
Administrative expenses | -31.64%-6.88M | -29.92%-2.93M | -21.19%-5.23M | -10.33%-2.25M | 13.56%-4.31M | 15.48%-2.04M | 5.88%-4.99M | 5.96%-2.42M | -14.24%-5.3M | -26.05%-2.57M |
Impairment and provision | 3.01%-451K | ---- | ---465K | ---- | ---- | ---- | ---- | ---- | ---661K | ---- |
-Other impairment is provision | 3.01%-451K | ---- | ---465K | ---- | ---- | ---- | ---- | ---- | ---661K | ---- |
Operating interest expense | ---- | -2,825.00%-117K | ---- | ---4K | ---- | ---- | ---- | ---- | ---- | ---12K |
Special items of operating profit | 63.89%4.51M | 159.58%1.97M | 201.32%2.75M | 46.42%757K | -243.30%-2.72M | -22.26%517K | 136.41%1.9M | 88.92%665K | 1,062.32%802K | 104.65%352K |
Operating profit | 127.03%230K | -70.14%-849K | 78.74%-851K | -89.02%-499K | -27.93%-4M | 87.76%-264K | 58.84%-3.13M | -160.19%-2.16M | -594.92%-7.6M | -154.90%-829K |
Financing cost | -320.00%-252K | ---- | ---60K | ---- | ---- | ---- | ---- | ---- | 67.50%-13K | ---- |
Share of profit from joint venture company | ---- | ---198K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Earning before tax | 97.59%-22K | -109.82%-1.05M | 77.24%-911K | -89.02%-499K | -27.93%-4M | 87.76%-264K | 58.91%-3.13M | -160.19%-2.16M | -609.02%-7.62M | -155.67%-829K |
Tax | --15K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 106.32%48K | ---- |
After-tax profit from continuing operations | 99.23%-7K | -109.82%-1.05M | 77.24%-911K | -89.02%-499K | -27.93%-4M | 87.76%-264K | 58.65%-3.13M | -160.19%-2.16M | -1,126.73%-7.57M | -167.56%-829K |
Earning after tax | 99.23%-7K | -109.82%-1.05M | 77.24%-911K | -89.02%-499K | -27.93%-4M | 87.76%-264K | 58.65%-3.13M | -160.19%-2.16M | -1,126.73%-7.57M | -167.56%-829K |
Minority profit | ---1K | ---- | ---- | ---- | ---1K | ---- | ---- | ---- | ---3K | ---- |
Profit attributable to shareholders | 99.34%-6K | -109.82%-1.05M | 77.24%-911K | -89.02%-499K | -27.90%-4M | 87.76%-264K | 58.63%-3.13M | -160.19%-2.16M | -1,126.32%-7.56M | -167.56%-829K |
Basic earnings per share | 0 | -120.00%-0.0011 | 77.27%-0.001 | -66.67%-0.0005 | -29.41%-0.0044 | 87.50%-0.0003 | 62.22%-0.0034 | -140.00%-0.0024 | -1,100.00%-0.009 | -152.63%-0.001 |
Diluted earnings per share | 0 | -120.00%-0.0011 | 77.27%-0.001 | -66.67%-0.0005 | -29.41%-0.0044 | 87.50%-0.0003 | 62.22%-0.0034 | -140.00%-0.0024 | -1,100.00%-0.009 | -152.63%-0.001 |
Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Qualified opinion | -- | Qualified opinion | -- | Qualified opinion | -- | Qualified opinion | -- | Unqualified Opinion | -- |
Auditor | Baker Tilly TFW LLP | -- | Baker Tilly TFW LLP | -- | Baker Tilly TFW LLP | -- | Baker Tilly TFW LLP | -- | Deloitte & Touche LLP | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data